Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06809933 · ClinicalTrials.gov registry record · NA

Exercise and Movement to Enhance Resiliency in Cancer Patients

A NA study of Gynecologic Cancer, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06809933 is a NA study of Gynecologic Cancer that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 763-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06809933, a NA study of Gynecologic Cancer, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.

Conditions Studied

Interventions

  • OTHER Digital Health Mobile App
  • OTHER Virtual Support Group
  • OTHER Health Coaching
  • OTHER FitBit
  • OTHER Handouts

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-03-24
Est. Completion 2031-08-31
Phase NA

What the Registry Record Tells You About NCT06809933

The ClinicalTrials.gov registry entry for NCT06809933 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 763-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (92% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gynecologic Cancer appearing as the primary indexed condition, and to 5 interventions - of which Digital Health Mobile App is the first listed.

NCT06809933 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06809933 about?

NCT06809933 is a clinical study titled "Exercise and Movement to Enhance Resiliency in Cancer Patients". This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatm...

What is the current status of trial NCT06809933?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-24. Estimated completion is 2031-08-31.

What conditions does trial NCT06809933 study?

This clinical trial studies the following conditions: Gynecologic Cancer.

What interventions are being tested in trial NCT06809933?

The interventions under investigation include: Digital Health Mobile App (OTHER), Virtual Support Group (OTHER), Health Coaching (OTHER), FitBit (OTHER), Handouts (OTHER).

Who is sponsoring clinical trial NCT06809933?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06809933 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gynecologic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.